Asphyxia Neonatorum Clinical Trial
— VISNATOfficial title:
Effects of Probiotic Mixture Supplementation and Evaluation of Intestinal Mucosal Tolerance and Gut Microbiome in Newborns With Perinatal Asphyxia Receiving Hypothermic Treatment: a Randomized, Multicentric, Blinded, Controlled Trial
Verified date | October 2019 |
Source | Policlinico Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The VISNAT trial is a PILOT STUDY due to absence of previous evidences in literature on using
probiotic in newborns with perinatal asphyxia.
It is designed as a randomized, placebo-controlled, blinded, multicentre superiority trial
with two parallel groups and a primary outcome of mortality and/or disability at 18 months of
age.
After informed consent is obtained from both parents, randomization will be performed as
block randomization with a 1:1 allocation using a computer-generated allocation sequence,
while the allocation concealment will be performed using locked bags.
Randomization data and allocation list will be stored in a secure place and will not be
available to any of the components of the study apart of data collectors.
Participant files will be stored for a period of 10 years after completion of the study.
All the components of the study will be blinded including: participants and their parents,
healthcare providers, outcome assessors, data collectors, data analysts.
Status | Not yet recruiting |
Enrollment | 120 |
Est. completion date | January 1, 2022 |
Est. primary completion date | January 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 6 Hours |
Eligibility |
Inclusion Criteria: - o Newborns with gestational age >/= 35 weeks and birth weight >/= 1800 grams o Intrapartum asphyxia defined according at least one of the following: - APGAR index at 10 minutes </=5; - Resuscitation with endotracheal tube or mask IPPV for more then 10 minutes; - pH </= 7 or excess of base >/= 12 mmol/l on arterial blood gas (ABG) analysis within the first 60 minutes of life - Moderate/severe Hypoxic-ischemic encephalopathy assessed between 30 and 60 minutes of life according to Sarnat & Sarnat definition - Hypothermic treatment. According to the Italian national guidelines on Perinatal Asphyxia and Therapeutic Hypothermia, the hypothermic therapy will be started in the first six hours of life and will last 72 hours. Exclusion Criteria: - Inability to obtain the informed consent from both parents - Congenital major malformations or syndromes o Surgical diseases |
Country | Name | City | State |
---|---|---|---|
Italy | Nicola Laforgia | Bari | BA |
Lead Sponsor | Collaborator |
---|---|
Policlinico Hospital |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Morbidity | Severe disability according to BAYLEY MENTAL DEVELOPMENT IINDEX | 18 months | |
Primary | Mortality | Death | 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04070560 -
Effects of Delayed Cord Clamping During Resuscitation of Newborn Near Term and Term Infants
|
N/A | |
Completed |
NCT03357250 -
Biomarkers And Neurological Outcome in Neonates (BANON)
|
||
Completed |
NCT02572427 -
Resident Training Enhanced by New Innovations: Teleintubation
|
N/A | |
Completed |
NCT03354208 -
Asphyxia Associated Metabolite Biomarker Investigation (AAMBI)
|
||
Completed |
NCT00097097 -
Neonatal Resuscitation in Zambia
|
Phase 3 | |
Active, not recruiting |
NCT03133572 -
Neonatal Resuscitation With Supraglottic Airway Trial
|
N/A | |
Completed |
NCT01866358 -
Intraosseous Infusion for Neonatal Asphyxiated Resuscitation
|
N/A | |
Completed |
NCT00136708 -
First Breath: Neonatal Resuscitation in Developing Countries
|
N/A | |
Completed |
NCT04820504 -
Augmented Infant Resuscitator to Enhance Newborn Ventilation
|
N/A | |
Completed |
NCT03284528 -
Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"
|
N/A | |
Completed |
NCT03278847 -
Optimising Newborn Nutrition During Therapeutic Hypothermia.
|
||
Recruiting |
NCT04239508 -
Swiss Neonatal Network & Follow-up Group
|
||
Recruiting |
NCT04714775 -
Biomarkers And Neurological Outcome in Neonates 2
|
||
Active, not recruiting |
NCT05349175 -
Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement
|
N/A | |
Completed |
NCT03606278 -
Evaluation of Two Strategies for Debriefing in the Development of Skills for Neonatal Resuscitation
|
N/A | |
Completed |
NCT00147030 -
TOBY: a Study of Treatment for Perinatal Asphyxia
|
N/A | |
Withdrawn |
NCT03913533 -
Heart Rate Assessment at Birth Comparing Stethoscope Versus Tap-based Application
|
N/A | |
Recruiting |
NCT04867993 -
Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With Hypothermia
|
N/A | |
Active, not recruiting |
NCT03179553 -
Heart Beat Variability in Neonatal Encephalopathy
|
||
Completed |
NCT03177980 -
Fentanyl and Clonidine for Analgesia During Hypothermia in Term Asphyxiated Infants
|